PRINCETON, N.J. - Soligenix Inc. (NASDAQ:SNGX) a annoncé aujourd’hui que son candidat-médicament SGX945 (dusquetide) a reçu la désignation Promising Innovative Medicine de la part de l’agence britanni ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results